Renato Skerlj News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Renato skerlj. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Renato Skerlj Today - Breaking & Trending Today

VC Daily: Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs

VC Daily: Expansion Therapeutics Gets $80 Million for RNA-Targeted Drugs
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Redwood City , City Of , United Kingdom , San Francisco , Biree Andemariam , Perumal Gandhi , Nick Nieslanik , Shahram Hejazi , Barbara Schilberg , Robert Iger , Aryan Pandya , Alpha Edison , Theresa Tribble , Northpond Adam Wieschhaus , Brandon Atkinson , Leonardo Dicaprio , Anderson Stowe , Breht Feigh , Melissa Daniels , Renato Skerlj , Kytopen Corp , Ionis Pharmaceuticals Inc , Uconn Health , Centene Corp ,

Expansion Therapeutics Raises $80M in Series B Financing

Expansion Therapeutics Raises $80M in Series B Financing
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

United States , Renato Skerlj , Kleiner Perkins , Matthewd Disney , Expansion Therapeutics Inc , Scripps Research , Novartis Venture Fund , Expansion Therapeutics , Cormorant Asset Management , Westlake Village Biopartners , Surveyor Capital , Logos Capital , Sanofi Ventures , Novartis Venture , Chief Executive Officer ,

Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research


Published: May 06, 2021
 
 
BOSTON (BUSINESS WIRE) Expansion Therapeutics., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today announced the appointment of Valerie Cullen, Ph.D., to Senior Vice President of Research.
“Valerie’s depth and breadth of research experience in drug development for neurological diseases, including leading complex programs at the intersection of research, translation and clinical development, will be tremendously valuable to our company,” said Renato Skerlj, Chief Executive Officer and President of Expansion Therapeutics. “We are fortunate to have her leadership as we advance our portfolio of small molecule medicines to treat RNA-mediated diseases in patients who currently have limited or no treatment options.” ....

United States , City Of , United Kingdom , Proclara Biosciences , Valerie Cullen , Renato Skerlj , Matthewd Disney , Scripps Research Institute , King College London , Program Lead At Lysosomal Therapeutics Inc , University College Dublin , Harvard Medical School , Senior Vice President , Chief Executive Officer , Vice President , Program Lead , Lysosomal Therapeutics , Link Medicine , College London , Harvard Medical , ஒன்றுபட்டது மாநிலங்களில் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , வலேரி கல்லன் , ஸ்கிரிப்ட்கள் ஆராய்ச்சி நிறுவனம் , கிங் கல்லூரி லண்டன் ,